Stocks

The table gives an overview of all stocks, alphabetically sorted.
 A-Mark Precious Metals, Inc. AMRK Dec 1, 2020 29.63 -3.14   
 A.H. Belo Corporation (TX) AHC Dec 1, 2020 1.48 -1.99   
 A.O. Smith Corporation AOS Dec 1, 2020 55.06 -2.22   
 A10 Networks, Inc. ATEN Dec 1, 2020 7.98 0.00   
 AAA - A Rated Corporate Bond Ishares QLTA Dec 1, 2020 58.40 -0.63   
 AAON, Inc. AAON Dec 1, 2020 64.24 -1.37   
 AAR Corp. AIR Dec 1, 2020 30.66 +8.07   
 Aarons Holdings Company, Inc. AAN Dec 1, 2020 62.93 0.00   
 ABB Ltd ABB Dec 1, 2020 26.67 +1.25   
 Abbott Laboratories ABT Dec 1, 2020 108.49 +0.25   
 AbbVie Inc. ABBV Dec 1, 2020 104.04 -0.52   
 Abcam plc - American Depositary Shares ABCM Dec 1, 2020 19.28 0.00   
 Abeona Therapeutics Inc. ABEO Dec 1, 2020 1.52 -6.17   
 Abercrombie & Fitch Company ANF Dec 1, 2020 20.21 -2.56   
 Aberdeen Asia-Pacific Income Fund Inc FAX Dec 1, 2020 4.20 0.00   
 Aberdeen Australia Equity Fund Inc IAF Dec 1, 2020 5.09 +0.79   
 Aberdeen Emerging Markets Equity Income Fund, Inc. AEF Dec 1, 2020 7.71 +2.12   
 Aberdeen Global Dynamic Dividend Fund AGD Dec 1, 2020 10.14 +1.50   
 Aberdeen Global Income Fund, Inc. FCO Dec 1, 2020 7.57 +0.07   
 Aberdeen Global Premier Properties Fund AWP Dec 1, 2020 5.22 +0.97   
 Aberdeen Income Credit Strategies Fund ACP Dec 1, 2020 10.56 +2.03   
 Aberdeen Japan Equity Fund, Inc. JEQ Dec 1, 2020 9.42 +1.40   
 Aberdeen Standard Global Infrastructure Income Fund ASGI Dec 1, 2020 18.20 +0.52   
 Aberdeen Total Dynamic Dividend Fund AOD Dec 1, 2020 8.70 +1.64   
 ABIOMED, Inc. ABMD Dec 1, 2020 268.21 -2.15   
 ABM Industries Incorporated ABM Dec 1, 2020 38.95 +1.17   
 Abraxas Petroleum Corporation AXAS Dec 1, 2020 2.19 -7.20   
 Absolute Software Corp ABST Dec 1, 2020 10.18 0.00   
 AC Immune SA ACIU Dec 1, 2020 5.49 -0.90   
 Acacia Communications, Inc. ACIA Dec 1, 2020 69.92 +0.34   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
Free Trial Now